Hum. Reprod. Advance Access originally published online on January 29, 2007
Human Reproduction 2007 22(5):1443-1449; doi:10.1093/humrep/del506
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of
-thalassaemia: a pilot study
1 Centre for Human Reproduction, Genesis Hospital, Athens, Greece 2 Laboratory of Medical Genetics, Athens University 3 Research Institute for the Study of Genetic and Malignant Disorders in Childhood, St Sophia's Children's Hospital, Athens, Greece 4 Monash Immunology and Stem Cell Laboratories, Monash University, Melbourne, Australia 5 Monash IVF, Melbourne, Australia
6 To whom correspondence should be addressed at: Center for Human Reproduction, Genesis Hospital, Papanikoli Avenue 14-16, Halandri, Athens 152-32, Greece. E-mail: georgiakokkali{at}mail.com
BACKGROUND: Trophectoderm biopsy at the blastocyst stage is an emerging approach in preimplantation genetic diagnosis (PGD). This study aimed to compare genotyping success and implantation rates in PGD cycles for
-thalassaemia following biopsy at the cleavage versus the blastocyst stage, with transfer of blastocysts.
METHODS: This pilot study included 20 cycles: Group A: 10 cycles, day 3 blastomere biopsy, day 5 transfer; Group B: 10 cycles, day 5 trophectoderm biopsy, day 6 transfer. Standard-assisted reproduction and laser biopsy procedures were used. Biopsied cells were genotyped using real-time PCR multiplexed with fluorescent microsatellite analysis.
RESULTS: In Group A, 131 fertilized eggs developed to 101 embryos suitable for single blastomere biopsy; 76/101 blastomeres were diagnosed (75.2%), 30 unaffected blastocysts were transferred resulting in six pregnancies (eight fetal hearts, 26.7% implantation rate). In Group B, 128 fertilized eggs developed to 53 blastocysts for trophectoderm biopsy (four to five cells), with 50/53 blastocysts diagnosed (94.3%), 21 unaffected blastocysts transferred and 6 pregnancies initiated (10 fetal hearts, 47.6% implantation rate). Overall, nine pregnancies reached >10 weeks gestation and were confirmed unaffected by prenatal diagnosis, with 12 healthy babies born.
CONCLUSIONS: This pilot study suggests that trophectoderm biopsy and blastocyst transfer may be more advantageous than cleavage stage biopsy with respect to outcome of PGD for monogenic diseases.
Key words:
biopsy/blastocyst/laser/preimplantation genetic diagnosis/
-thalassaemia
Submitted on November 24, 2005; resubmitted on July 4, 2006; resubmitted on September 21, 2006; accepted on September 25, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E Turillazzi and V Fineschi Preimplantation genetic diagnosis: a step by step guide to recent Italian ethical and legislative troubles J. Med. Ethics, October 1, 2008; 34(10): e21 - e21. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Jones, D. S. Cram, B. Song, G. Kokkali, K. Pantos, and A. O. Trounson Novel strategy with potential to identify developmentally competent IVF blastocysts Hum. Reprod., August 1, 2008; 23(8): 1748 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fragouli, M. Lenzi, R. Ross, M. Katz-Jaffe, W.B. Schoolcraft, and D. Wells Comprehensive molecular cytogenetic analysis of the human blastocyst stage Hum. Reprod., July 29, 2008; (2008) den287v1. [Abstract] [Full Text] [PDF] |
||||

